Table 1 Subject characteristic for those enrolled in study
|  | Control (n = 81) | IVH1/2 (n = 29) | IVH3/4 (n = 13) | PHH (n = 15) | BM (n = 20) | VM (n = 27) | All patients (n = 185) |
|---|---|---|---|---|---|---|---|
Birth EGA (weeks) | 37.1 ± 3.3 | 33.4 ± 5.3 | 27.6 ± 5.7 | 26.6 ± 3.1 | 36.6 ± 4.5 | 37.2 ± 3 | 35 ± 5.3 |
Sample EGA (weeks) | 40.4 ± 2.2 | 35.8 ± 4.6 | 32.4 ± 6.1 | 29.4 ± 2.8 | 38.9 ± 4.3 | 40.8 ± 1.7 | 38. ± 4.9 |
Gender (% male) | 54.3 | 69.0 | 61.5 | 73.3 | 45.0 | 59.2 | 58.4 |
Postnatal steroids (%) | 2.5 | 17.2 | 0.00 | 25.0 | 5.0 | 0.0 | 8.1 |
PROM (%) | 9.3 | 35 | 23 | 40 | 15.38 | 4.34 | 13.51 |
Chorioamnionitis (%) | 7.4 | 10.34 | 23.07 | 6.66 | 5 | 0 | 7.56 |
Lung disease (%) | 9.87 | 27.58 | 23.07 | 73.33 | 35 | 0 | 20 |
Sepsis (%) | 3.75 | 34.48 | 46.15 | 33.33 | 20 | 0 | 15.13 |